Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases

Gillian Bedard, Saurabh Ray, Liying Zhang, Liang Zeng, David Cella, Erin Wong, Cyril Danjoux, May Tsao, Elizabeth Barnes, Arjun Sahgal, Lori Holden, Natalie Lauzon, Edward Chow

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

OBJECTIVE: To validate the Brain Symptom and Impact Questionnaire (BASIQ) version 1.0 for brain metastases.

METHODS: Patients with brain metastases and their healthcare professionals (HCPs) assessed the relevance of the BASIQ on a 0-10 scale with 10 as extremely relevant.

RESULTS: A total of 52 patients and 20 HCPs participated in this study. In total, 95% of HCPs and 85% of patients found all items relevant. Balance and walking ability were rated relevant by 100% of patients and HCPs. Headache, nausea, energy, memory and ability to do housework were also rated relevant by 100% of HCPs. Over 95% of patients determined the items of ability to do housework, tiredness, energy, vision, memory and putting ideas into words as relevant. There were no items rated below 7 by patients or below 5 by HCPs.

CONCLUSION: This study indicates that BASIQ version 1.0 has valid content items encompassing disease-related symptom and impact on daily living.

Original languageEnglish (US)
Pages (from-to)275-285
Number of pages11
JournalCNS oncology
Volume3
Issue number4
DOIs
StatePublished - Jul 1 2014

Keywords

  • BASIQ
  • brain metastases
  • content validation
  • quality of life
  • questionnaire

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases'. Together they form a unique fingerprint.

  • Cite this

    Bedard, G., Ray, S., Zhang, L., Zeng, L., Cella, D., Wong, E., Danjoux, C., Tsao, M., Barnes, E., Sahgal, A., Holden, L., Lauzon, N., & Chow, E. (2014). Validation of the Brain Symptom and Impact Questionnaire (BASIQ) to assess symptom and quality of life in brain metastases. CNS oncology, 3(4), 275-285. https://doi.org/10.2217/cns.14.28